Eclipsebio’s eVERSE™ provides access to AI-ready data from their comprehensive portfolio of next-generation sequencing technologies, including measurements of RNA secondary structure, protein translation, and regulatory regions. Eclipsebio’s partners can improve AI-powered drug discovery with reproducible and high-quality data capturing key determinants of siRNA, ASO, and mRNA-based therapy efficacy. Eclipse Bioinnovations, the leading partner for …
Eclipsebio launches eVERSE™, a first‑of‑its‑kind comprehensive portfolio of RNA‑focused datasets for AI model success
Share.
